Epigenetic basis of opiate suppression of Bdnf gene expression in the ventral tegmental area

Nature Neuroscience

Volumn 18, Issue 3, 2015, Pages 415-425

  Koo, Ja Wook ^a   Mazei Robison, Michelle S ^a,b   Laplant, Quincey ^a   Egervari, Gabor ^a   Braunscheidel, Kevin M ^c   Adank, Danielle N ^c   Ferguson, Deveroux ^a   Feng, Jian ^a   Sun, Haosheng ^a   Scobie, Kimberly N ^a   Damez Werno, Diane M ^a   Ribeiro, Efrain ^a   Peña, Catherine Jensen ^a   Walker, Deena ^a   Bagot, Rosemary C ^a   Cahill, Michael E ^a   Anderson, Sarah Ann R ^a   Labonté, Benoit ^a   Hodes, Georgia E ^a   Browne, Heidi ^a   Chadwick, Benjamin ^a   Robison, Alfred J ^a,b   Vialou, Vincent F ^a,d   Dias, Caroline ^a   Lorsch, Zachary ^a   Mouzon, Ezekiell ^a   Lobo, Mary Kay ^e   Dietz, David M ^d   Russo, Scott J ^a   Neve, Rachael L ^f   Hurd, Yasmin L ^a   Nestler, Eric J ^a   more..

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d CNRS   (France)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HISTONE H3; MORPHINE; NUCLEAR RECEPTOR RELATED FACTOR 1; RNA POLYMERASE II; COCAINE; DOPAMINE UPTAKE INHIBITOR; EZH2 PROTEIN, MOUSE; NARCOTIC ANALGESIC AGENT; POLYCOMB REPRESSIVE COMPLEX 2;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DERIVED NEUROTROPHIC FACTOR GENE; CONTROLLED STUDY; DNA MODIFICATION; DOWN REGULATION; EPIGENETICS; GENE; GENE REPRESSION; HEROIN DEPENDENCE; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; HUMAN TISSUE; LONG TERM EXPOSURE; MALE; NERVE CELL PLASTICITY; NONHUMAN; OPIATE ADDICTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; RAT; VENTRAL TEGMENTUM; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; INSTRUMENTAL CONDITIONING; METABOLISM; MOTOR ACTIVITY; MOUSE; PATHOLOGY; PHYSIOLOGY; POSTMORTEM CHANGE; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE;

ANALGESICS, OPIOID; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; COCAINE; CONDITIONING, OPERANT; DOPAMINE UPTAKE INHIBITORS; EPIGENESIS, GENETIC; HEROIN DEPENDENCE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; POLYCOMB REPRESSIVE COMPLEX 2; POSTMORTEM CHANGES; RATS; RATS, SPRAGUE-DAWLEY; RNA POLYMERASE II; VENTRAL TEGMENTAL AREA;

EID: 84923823158     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.3932     Document Type: Article

References (66)

1. Lobo, M.K. et al. Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 330, 385-390 (2010).
2. Pu, L., Liu, Q.S. & Poo, M.M. BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal. Nat. Neurosci. 9, 605-607 (2006).
3. Russo, S.J., Mazei-Robison, M.S., Ables, J.L. & Nestler, E.J. Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56 (suppl. 1), 73-82 (2009).
4. Filip, M. et al. Alterations in BDNF and trkB mRNAs following acute or sensitizing cocaine treatments and withdrawal. Brain Res. 1071, 218-225 (2006).
5. Graham, D.L. et al. Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat. Neurosci. 10, 1029-1037 (2007).
6. Grimm, J.W. et al. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J. Neurosci. 23, 742-747 (2003).
7. Graham, D.L. et al. Tropomyosin-related kinase B in the mesolimbic dopamine system: region-specific effects on cocaine reward. Biol. Psychiatry 65, 696-701 (2009).
8. Hall, F.S., Drgonova, J., Goeb, M. & Uhl, G.R. Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. Neuropsychopharmacology 28, 1485-1490 (2003).
9. Horger, B.A. et al. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J. Neurosci. 19, 4110-4122 (1999).
10. Lu, L., Dempsey, J., Liu, S.Y., Bossert, J.M. & Shaham, Y. A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J. Neurosci. 24, 1604-1611 (2004).
11. Koo, J.W. et al. BDNF is a negative modulator of morphine action. Science 338, 124-128 (2012).
12. Berhow, M.T. et al. Influence of neurotrophic factors on morphine- and cocaineinduced biochemical changes in the mesolimbic dopamine system. Neuroscience 68, 969-979 (1995).
13. Russo, S.J. et al. IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat. Neurosci. 10, 93-99 (2007).
14. Sklair-Tavron, L. et al. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc. Natl. Acad. Sci. USA 93, 11202-11207 (1996).
15. Mazei-Robison, M.S. et al. Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons. Neuron 72, 977-990 (2011).
16. Aid, T., Kazantseva, A., Piirsoo, M., Palm, K. & Timmusk, T. Mouse and rat BDNF gene structure and expression revisited. J. Neurosci. Res. 85, 525-535 (2007).
17. Vanderschuren, L.J. et al. Morphine-induced long-term sensitization to the locomotor effects of morphine and amphetamine depends on the temporal pattern of the pretreatment regimen. Psychopharmacology (Berl.) 131, 115-122 (1997).
18. Komarnitsky, P., Cho, E.J. & Buratowski, S. Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev. 14, 2452-2460 (2000).
19. Laherty, C.D. et al. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89, 349-356 (1997).
20. Shi, X. et al. ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 442, 96-99 (2006).
21. Ythier, D. et al. Sumoylation of ING2 regulates the transcription mediated by Sin3A. Oncogene 29, 5946-5956 (2010).
22. Czermin, B. et al. Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites. Cell 111, 185-196 (2002).
23. Müller, J. et al. Histone methyltransferase activity of a Drosophila Polycomb group repressor complex. Cell 111, 197-208 (2002).
24. Simon, J.A. & Kingston, R.E. Mechanisms of polycomb gene silencing: knowns and unknowns. Nat. Rev. Mol. Cell Biol. 10, 697-708 (2009).
25. Cao, R., Tsukada, Y. & Zhang, Y. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol. Cell 20, 845-854 (2005).
26. Tao, X., West, A.E., Chen, W.G., Corfas, G. & Greenberg, M.E. A calcium-responsive transcription factor, CaRF, that regulates neuronal activity-dependent expression of BDNF. Neuron 33, 383-395 (2002).
27. Walters, C.L., Kuo, Y.C. & Blendy, J.A. Differential distribution of CREB in the mesolimbic dopamine reward pathway. J. Neurochem. 87, 1237-1244 (2003).
28. Olson, V.G. et al. Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area. J. Neurosci. 25, 5553-5562 (2005).
29. Xiong, Y. et al. Polycomb antagonizes p300/CREB-binding protein-associated factor to silence FOXP3 in a Kruppel-like factor-dependent manner. J. Biol. Chem. 287, 34372-34385 (2012).
30. Volpicelli, F. et al. Direct regulation of Pitx3 expression by Nurr1 in culture and in developing mouse midbrain. PLoS ONE 7, e30661 (2012).
31. Volpicelli, F. et al. Bdnf gene is a downstream target of Nurr1 transcription factor in rat midbrain neurons in vitro. J. Neurochem. 102, 441-453 (2007).
32. Barneda-Zahonero, B. et al. Nurr1 protein is required for N-methyl-d-aspartic acid (NMDA) receptor-mediated neuronal survival. J. Biol. Chem. 287, 11351-11362 (2012).
33. Kadkhodaei, B. et al. Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons. J. Neurosci. 29, 15923-15932 (2009).
34. McEvoy, A.N. et al. Activation of nuclear orphan receptor NURR1 transcription by NF-kappa B and cyclic adenosine 52-monophosphate response element-binding protein in rheumatoid arthritis synovial tissue. J. Immunol. 168, 2979-2987 (2002).
35. Chu, N.N. et al. Peripheral electrical stimulation reversed the cell size reduction and increased BDNF level in the ventral tegmental area in chronic morphine-treated rats. Brain Res. 1182, 90-98 (2007).
36. Vargas-Perez, H. et al. Ventral tegmental area BDNF induces an opiate-dependentlike reward state in naive rats. Science 324, 1732-1734 (2009).
37. Fujii, S., Ito, K., Ito, Y. & Ochiai, A. Enhancer of zeste homologue 2 (EZH2) downregulates RUNX3 by increasing histone H3 methylation. J. Biol. Chem. 283, 17324-17332 (2008).
38. van der Vlag, J. & Otte, A.P. Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation. Nat. Genet. 23, 474-478 (1999).
39. Milne, T.A. et al. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol. Cell 10, 1107-1117 (2002).
40. Xia, Z.B., Anderson, M., Diaz, M.O. & Zeleznik-Le, N.J. MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the co-repressor C terminal-binding protein. Proc. Natl. Acad. Sci. USA 100, 8342-8347 (2003).
41. Rios, M. et al. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol. Endocrinol. 15, 1748-1757 (2001).
42. Covington, H.E. III et al. A role for repressive histone methylation in cocaine-induced vulnerability to stress. Neuron 71, 656-670 (2011).
43. Anderson, S.A. et al. Impaired periamygdaloid-cortex prodynorphin is characteristic of opiate addiction and depression. J. Clin. Invest. 123, 5334-5341 (2013).
44. Barrot, M. et al. CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc. Natl. Acad. Sci. USA 99, 11435-11440 (2002).
45. Dietz, D.M. et al. Rac1 is essential in cocaine-induced structural plasticity of nucleus accumbens neurons. Nat. Neurosci. 15, 891-896 (2012).
46. Liu, Q.R. et al. Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine. Brain Res. 1067, 1-12 (2006).
47. Livak, K.J. & Schmittgen, T.D. Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408 (2001).
48. Schmidt, H.D. et al. Increased brain-derived neurotrophic factor (BDNF) expression in the ventral tegmental area during cocaine abstinence is associated with increased histone acetylation at BDNF exon I-containing promoters. J. Neurochem. 120, 202-209 (2012).
49. Xu, Y.X. & Manley, J.L. Pin1 modulates RNA polymerase II activity during the transcription cycle. Genes Dev. 21, 2950-2962 (2007).
50. Sandoval, J. et al. RNAPol-ChIP: a novel application of chromatin immunoprecipitation to the analysis of real-time gene transcription. Nucleic Acids Res. 32, e88 (2004).
51. Egloff, S., Al-Rawaf, H., O'Reilly, D. & Murphy, S. Chromatin structure is implicated in "late" elongation checkpoints on the U2 snRNA and beta-actin genes. Mol. Cell. Biol. 29, 4002-4013 (2009).
52. Khobta, A., Anderhub, S., Kitsera, N. & Epe, B. Gene silencing induced by oxidative DNA base damage: association with local decrease of histone H4 acetylation in the promoter region. Nucleic Acids Res. 38, 4285-4295 (2010).
53. Weishaupt, H. & Attema, J.L. A method to study the epigenetic chromatin states of rare hematopoietic stem and progenitor cells: MiniChIP-Chip. Biol. Proced. Online 12, 1-17 (2010).
54. Nitzsche, A., Steinhausser, C., Mucke, K., Paulus, C. & Nevels, M. Histone H3 lysine 4 methylation marks postreplicative human cytomegalovirus chromatin. J. Virol. 86, 9817-9827 (2012).
55. Gilfillan, G.D. et al. Limitations and possibilities of low cell number ChIP-seq. BMC Genomics 13, 645 (2012).
56. Marchesi, I., Fiorentino, F.P., Rizzolio, F., Giordano, A. & Bagella, L. The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation. Cell Cycle 11, 3828-3836 (2012).
57. Lee, T.I. et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125, 301-313 (2006).
58. Schaefer, A. et al. Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex. Neuron 64, 678-691 (2009).
59. Ren, G. et al. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer Res. 72, 3091-3104 (2012).
60. Rotman, N., Guex, N., Gouranton, E. & Wahli, W. PPARbeta interprets a chromatin signature of pluripotency to promote embryonic differentiation at gastrulation. PLoS ONE 8, e83300 (2013).
61. Basu, A., Wilkinson, F.H., Colavita, K., Fennelly, C. & Atchison, M.L. YY1 DNA binding and interaction with YAF2 is essential for Polycomb recruitment. Nucleic Acids Res. 42, 2208-2223 (2014).
62. Richly, H. et al. Transcriptional activation of polycomb-repressed genes by ZRF1. Nature 468, 1124-1128 (2010).
63. Mao, L. et al. Cyclin E1 is a common target of BMI1 and MYCN and a prognostic marker for neuroblastoma progression. Oncogene 31, 3785-3795 (2012).
64. Ellison-Zelski, S.J., Solodin, N.M. & Alarid, E.T. Repression of ESR1 through actions of estrogen receptor alpha and Sin3A at the proximal promoter. Mol. Cell. Biol. 29, 4949-4958 (2009).
65. Pellegrini, M. et al. Expression profile of CREB knockdown in myeloid leukemia cells. BMC Cancer 8, 264 (2008).
66. Sakurada, K., Ohshima-Sakurada, M., Palmer, T.D. & Gage, F.H. Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development 126, 4017-4026 (1999).